Cologne, Germany, April 11, 2013. Direvo Industrial Biotechnology GmbH has joined a group of
stakeholders from the biobased industry contributing to BRIDGE, a European Commission public-
private partnership (PPP). BRIDGE stands for „Biobased and Renewable Industries for Development
and Growth in Europe?. The aim is to foster biobased industrial development in Europe by bridging the
gap from research to the marketplace. Direvo is the only Small and Medium Enterprise (SME) from
Europe which is directly engaged in the BRIDGE PPP.
BIC, a Biobased Industries Consortium, has already made available 2.8 billion EUR for the PPP. This
amount shall be complemented by 1 billion EUR from the European Research Funding. The final
decision about program and budget is expected to be made at the end of this year.
The PPP is being established in cooperation of the European Commission and the biobased industry
as an integrated and fundamental tool under Horizon 2020, the 8th
EU framework program aimed at
securing Europe?s global competitiveness, and the Strategy and Action Plan for Sustainable
Bioeconomy in Europe. The industry is organized in a consortium including more than 40 European
companies and organizations across technology, industry, agriculture and forestry, among them
Novozymes, DSM, Clariant and Unilever. The consortium was established on February 28, 2013 in
“It is important for Europe to bring together its most innovative companies and clusters under one roof
to boost a truly biobased economy. With great pleasure and pride, Direvo engages in this Partnership.”
said Jorg Riesmeier, CEO of Direvo. “Our research platform BluCon® for the transformation of
cellulosic biomass to valuable chemicals and our BluServ™ Service Portfolio for tailor-made biobased
solutions will surely enrich this consortium.”
BRIDGE is a Public Private Partnership between the European Commission and biobased industries
and stands for „Biobased and Renewable Industries for Development and Growth in Europe?. To
strengthen Europe as a competitive, innovative and sustainable economy, BRIDGE will focus on three
different areas of activities:
1. Building new biobased value chains based on the development of sustainable biomass collection
and supply systems with increased productivity, and improved utilization of biomass feedstock.
2. Bringing existing value chains to new levels, through optimized uses of feed and industrial side-
streams, and offering new added value products to market.
3. Bringing technology to maturity through research and innovation, and trough upgrading and building
demonstration and flagship biorefineries.
More Information on BRIDGE can be found at www.bridge2020.eu.
About Direvo Industrial Biotechnology GmbH:
Direvo is a biotechnology company with focus on the biomass conversion industry. Direvo identifies
bottlenecks and weaknesses in current industrial processes in this sector and develops and
implements biology-based solutions together with large and small industrial partners. Direvo?s
products are newly designed enzymes and microorganisms of the highest quality that provide easy-to-
implement, cost-effective solutions. Direvo?s contribution assures that partners stay competitive and
profitable while supporting them to make the future cleaner, greener and safer. More information about
Direvo is available on www.direvo.com.
Dr. Albrecht Läufer
DIREVO Industrial Biotechnology GmbH
50829 Köln (Cologne)
Phone +49 221-47448-108
Fax +49 221-47448-111